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Abstract 
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a 
prospective population-based cohort study which recruited pregnant 
women in 1990-1992. The resource provides an informative and 
efficient setting for collecting data on the current coronavirus 2019 
(COVID-19) pandemic. In early March 2020, a questionnaire was 
developed in collaboration with other longitudinal population studies 
to ensure cross-cohort comparability. It targeted retrospective and 
current COVID-19 infection information (exposure assessment, 
symptom tracking and reported clinical outcomes) and the impact of 
both disease and mitigating measures implemented to manage the 
COVID-19 crisis more broadly. Data were collected on symptoms of 
COVID-19 and seasonal flu, travel prior to the pandemic, mental 
health and social, behavioural and lifestyle factors. 
The online questionnaire was deployed across the parent and 
offspring generations between the 9th April and 15th May 2020. 6807 
participants completed the questionnaire (2706 original mothers, 
1014 original fathers/partners, 2973 offspring (mean age ~28 years) 
and 114 partners of offspring). Eight (0.01%) participants (4 G0 and 4 
G1) reported a positive test for COVID-19, 77 (1.13%; 28 G0 and 49 G1) 
reported that they had been told by a doctor they likely had COVID-19 
and 865 (12.7%; 426 G0 and 439 G1) suspected that they have had 
COVID-19.  Using algorithmically defined cases, we estimate that the 
predicted proportion of COVID-19 cases fell between 1.03% - 4.19% 
depending on timing of measurement during the period of reporting. 
Data from this first questionnaire will be complemented with at least 
two more follow-up questionnaires, linkage to health records and 
results of biological testing as they become available. Data has been 
released as: 1) a standard dataset containing all participant responses 
with key sociodemographic factors and 2) as a composite release 
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Introduction
The coronavirus disease 2019 (COVID-19) pandemic is a 
rapidly developing global health challenge. There is marked 
heterogeneity in disease prevalence, severity and outcome 
both within and across populations. In part, this may be driven 
by the interplay between environmental, social and host factors 
such as age and pre-existing comorbidities which predispose 
or protect against infection or modify disease outcomes. 
Understanding this interplay requires studies with detailed 
environmental, health, lifestyle, and biological data – ideally 
measured within the context of longitudinal data and with 
prospective collection opportunities.
Alongside the health implications of the virus itself, the 
response to the pandemic is likely to affect health and wellbeing. 
Mitigation measures have resulted in far-reaching changes to 
daily activity (exemplified by the nationwide ‘lockdown’ strategy 
implemented in the UK from 23rd March 2020) which are 
likely to have an impact on nearly all aspects of work, family 
life, recreation and, potentially, health. Any adverse effects of 
these mitigation strategies may themselves be heterogeneous, 
with certain groups at higher risk of adverse effects. 
Understanding the effect of mitigation strategies on health and 
identifying the social, environmental, or other factors which 
help reduce their impact will be an important part of planning 
both ongoing and future COVID-19 mitigation strategies as the 
pandemic develops.
The Avon Longitudinal Study of Parents and Children 
(ALSPAC) is a unique three-generational study, comprising 
‘G0’: the cohort of original pregnant women, the biological 
father and other carers/partners; ‘G1’: the cohort of index chil-
dren and ‘G2’: the cohort of offspring of the index children. The 
study has a wealth of biological, genetic and phenotypic data 
across these generations1–4. ALSPAC has an opportunity to cap-
ture information across key parts of the population in light of the 
COVID-19 pandemic – in particular the contrast between those 
in higher risk (G0 mean age: ~58years) and lower risk (G1 mean 
age: ~28yrs) groups. We were well placed to collect data quickly 
using our existing infrastructure for online data collection.
The wider COVID-19 data collection in ALSPAC will 
include data from three main sources: self-reported data from 
questionnaires, data from clinical services based on linkage 
to medical and other records and though biological samples. 
The data from these sources are intended to be complementary 
and help address different potential research questions around 
COVID-19. This data note describes the data collected via our 
first online questionnaire between 9th April and 14th May 2020 
and provides a summary of the participants who responded. 
Updates on subsequent questionnaires and other sources of 
data will be released as these additional datasets are made 
available.
Methods
Setting
ALSPAC is an intergenerational longitudinal cohort that 
recruited pregnant women residing in Avon, UK with expected 
dates of delivery 1st April 1991 to 31st December 19921,2. 
The initial cohort consisted of 14,541 pregnancies result-
ing in 14,062 live births and 13,988 children who were alive at 
1 year of age. From the age of seven onwards, the initial sam-
ple was bolstered with eligible cases who had originally failed 
to join the study and there were subsequently 14,701 children 
alive at 1 year of age following this further recruitment3. Please 
note, the study website contains details of all the data that is 
available through a fully searchable data dictionary and variable 
search tool.
In response to the COVID-19 it was necessary to develop a 
data collection strategy which was practical, would yield data 
quickly and could be updated and repeated. For these rea-
sons, we chose to use an online only data collection approach 
for this, restricting our invites to those participants with a valid 
email address (and coordinated with a systematic communica-
tions/outreach campaign). The questionnaire was developed and 
deployed using REDCap (Research Electronic Data CAPture 
tools5); a secure web application for building and managing online 
data collection exercises, hosted at the University of Bristol.
Content design
Content was initially developed internally, we then consulted 
with a network of 16 UK and international longitudinal popu-
lation studies and partners through a process facilitated by 
Wellcome (see acknowledgements). This resulted in a core set 
and a recommended set of questions about health, behaviour, 
social, economic and environmental impact of COVID-19. 
Whilst we were able to align many features of the ALSPAC 
questionnaire and the Wellcome core questionnaire, there are 
some areas of divergence. This is because the ALSPAC question-
naire was deployed while the Wellcome core questionnaire was 
still being finalized, and because we chose to use mental health 
measures that we have used previously to facilitate longitudinal 
analyses rather than the Wellcome recommended measures. It 
is worth noting that ALSPAC is the contact point for using the 
Wellcome questionnaire and we can provide data dictionar-
ies in either REDCap or Qualtrics (via Generation Scotland) 
on request. This work is therefore part of a coordinated effort to 
generate and promote a Wellcome Trust supported core question-
naire. This is now complete and available and access to this can 
be organised through ALSPAC. The questionnaire has not been 
formally validated, however, extensive testing by our ethics 
committee, participant advisory group and ALSPAC staff led to 
clarity of wording and ensuring REDCap functionality worked as 
expected.
The questionnaire included 4 sections, and captured information on 
the following:
A. General health, recent travel and seasonal symptoms
•    Conditions making people high risk
•    Frailty assessed using PRISMA -76
•    Regular medications (prescription and over the 
counter)
•    Home country and travel outside that country since 
October 2019
Page 3 of 10
Wellcome Open Research 2020, 5:127 Last updated: 11 AUG 2020
•    Symptoms of COVID-19 and negative control 
symptoms since October 2019
•    Tested/diagnosed with COVID-19
B. Behaviour as a result of COVID-19
•    Self-isolation and reasons why
•    Behaviour changes prior to lockdown
•    Lifestyle changes since lockdown
•    Social contacts and methods of communication
C. Impact of the pandemic
•    Worries during the pandemic
•    Depression assessed using the Short Moods and 
Feelings questionnaire (SMFQ; 7) 
•    Anxiety assessed using the General Anxiety Disortder-7 
questionnaire (GAD7; 8)
•    Well-being assessed using the Warwick-Edinburgh 
Mental Wellbeing Scales (WEMWBS; 9)
D. About you during the pandemic
•    Understanding of official guidance on COVID-19
•    Time spent talking/reading about or listening to infor-
mation about COVID-19
•    Living arrangements
•    Healthcare worker and keyworker status
•    Effect of pandemic on plans to have children (G1 only)
•    Free text inviting participants to provide details of 
other ways they have been affected by the pandemic
The final questionnaire (REDCap PDF) used is available 
with the associated data dictionary (which includes frequen-
cies of all variables that are available) and both are available 
as extended data10.
Invitation and reminder strategy
Between the 9th and 15th April 2020, all participants (G0, 
G1 and G1 partners enrolled as part of G2 (children of the 
Children of the 90s4) for whom we had an active email 
address were sent an invitation to complete the questionnaire. 
Participants were not contacted if our administrative database 
record indicated that they were deceased, had withdrawn from 
the study, had declined further contact or had declined question-
naires. The questionnaire survey was live on the online platform 
for just over one month. After 2 weeks, any non-responders 
were sent a reminder email to complete the questionnaire. In 
addition, traditional (print, radio, tv) & social media (Facebook, 
Instagram and Twitter) were used to inform participants that the 
questionnaire was live, asking them to contact us if they had 
not received it and to encourage completion. These commu-
nication channels were also used to encourage re-engagement 
of friends and family back into the study. Unlike our standard 
questionnaires (usually completed annually) we did not provide 
any incentive for completion; however, we did offer a prize draw 
(three prizes of £100) for those who completed their questionnaire 
by 11th May.
Response rate
A total of 12,520 invitations were sent out and responses 
were received from 6811 participants (overall response rate 
of 54%). Over 4,000 participants completed the questionnaire 
within the first week of the invitation (see Figure 1), this repre-
sents a snapshot of participant experience around 3 weeks after 
the start of ‘lockdown’. The questionnaire was closed on 15th 
May 2020.
Overall, female participants were more likely to respond, and 
this was particularly true of the younger generation. A potential 
explanation for the difference in male response rates between 
younger and older participants we note that G0 fathers included 
in this data collection exercise are already relatively engaged 
with the study as they had to enrol in their own right in 2011 
as part of our ‘Focus on Fathers’ data collection (previously they 
were only invited to participate via the mother). The response 
from G1 males was disappointing and we aim to re-engage 
this group using targeted social media and other activities in 
the future. Table 1 summarises the response rate within each 
group organised by cohort structure.
Characteristics of responders according to key variables that 
will be released with the complete dataset can be seen in 
Table 2.
Key results
Participants were asked whether they thought they have had 
COVID-19. Options were: ‘Yes, confirmed by a positive 
test’, ‘Yes, suspected by a doctor but not tested’, ‘Yes, my 
own suspicions’ or ‘No’. Overall 8 respondents reported that 
they had tested positive to COVID-19 (when combined with 
participant group this information is potentially disclosive it will 
therefore be combined with ‘yes, suspected by a doctor’ to cre-
ate a new category in the released datasets ‘Yes, tested positive 
or suspected by a doctor’). Table 3 summarises the responses 
to this question by cohort structure. Due to small numbers 
we have had to combine the first two categories together for 
the released dataset.
Menni and Colleagues11 recently published a model combining 
symptoms to predict ‘probable infection’ using data collected 
from an app-based symptom tracker12. This algorithm uses 
four symptoms: loss of smell and taste, severe or significant 
persistent cough, severe fatigue and skipped meals (coded 
as 1 if present and 0 otherwise), together with age and sex 
(1 male; 0 female). We had slight difference in wording and 
thus the algorithm (using the same weightings) applied was as 
follows:
    -1.32 - (0.01 x age) + (0.44 x sex) + (1.75 x loss of loss of 
smell or taste)
    + (0.31 x new persistent cough) + (0.49 x severe fatigue)
    + (0.39 x decreased appetite).
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Probable COVID-19 cases were obtained by applying an exp(x)/
[1+(exp(x)] transformation and coding values >0.5 as prob-
able cases. We applied this algorithm to our monthly symp-
tom data and the number of predicted ‘cases’ each month are 
shown in Figure 2. We used Stata v.15.0 and our Stata do file is 
available as extended data10. Peak predicted cases were 
seen in March (4.19%) with similar proportions seen in all 
other months (2.10% - 2.38%), except November which was 
substantially lower (1.03%). Our figures were consistently 
lower than the 5.36% of responders to the app11 who were 
reported as likely being infected by the virus. Table 4 summa-
rises these predicted cases of COVID-19 each month accord-
ing to self-reported infection status. There is a clear temporal 
trend such that the proportion of predicted cases increases over 
time in those who self-reported that they had COVID-19.
Whilst we have presented these results as a mark of the type 
of analysis one can undertake using these data, we note that 
these predictions are subject to important assumptions. First, 
the baseline risk of having COVID-19 (intercept term in 
the model) is assumed to be the same in the ALSPAC study 
population as the Menni study population. This assumption 
may be invalid as there are fewer reported COVID-19 cases in 
South West England compared to other regions of the UK13, 
potentially over-estimating prevalence in ALSPAC. Secondly, the 
symptoms we termed ‘new persistent cough’, ‘severe fatigue’ and 
Table 1. Number of participants who were eligible and 
who responded to the first COVID-19 questionnaire.
Cohort Group Eligible1 Responded2
G0 Mothers 4590 2706 (59%)
G0 Fathers/partners 1803 1014 (56%)
G1 Offspring daughters 3617 2126 (59%)
G1 Offspring sons 2225 847 (38%)
G1 Offspring partners (female) 103 63 (61%)
G1 Offspring partners (male) 182 51 (28%)
TOTAL 12520 6807 (54%)
1valid email address, marked as contactable for questionnaires
2Proportions of those invited (i.e. eligible)
Figure 1. Completion rate by number of days questionnaire was live. Invitations were sent in batches over several days - G0 invitations 
did not start going out until 3 days after the questionnaire was live.
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Table 3. Participant response to whether they have had COVID-19.
G0 - parents G1 – offspring (+partners) Total
Yes, positive test 4 (0.01%) 4 (0.01%) 8 (0.01%)
Yes, doctor suspected, no test 28 (0.76%) 48 (1.56%) 76 (1.12%)
Yes, own suspicions 426 (11.5%) 439 (14.2%) 865 (12.8%)
No 3229 (87.4%) 2584 (83.8%) 5734 (84.6%)
Table 2. Summary of key characteristics for those who responded; n (%) for 
categorical variables or mean (sd) for continuous variables.
Mothers Fathers/ 
partners
Offspring Offspring 
partners
Age (years) 57.9 (4.44) 60.8 (5.17) 27.6 (0.54) 29.9 (4.37)
Latest BMI1 26.3 (5.01) 27.4 (3.98) 24.6 (5.25) 27.1 (4.89)
Latest Systolic BP1 119.4 (14.10) 132.9 (13.77) 115.2 (10.83) 116.3 
(12.44)
Latest Diastolic BP1 70.6 (9.33) 77.2 (9.03) 66.7 (7.77) 65.9 (9.97)
Education level2 
≥A level
1385 
(53.7%) 674 (70.4%)
1793 
(77.8%) 26 (60.5%)
Ethnicity3 
White
2533 
(98.4%) 948 (99.2%)
2559 
(96.6%)
Not 
available
1Data taken from the most recent clinic that individual attended where available
2Data taken from pregnancy questionnaires for G0 and from most recent questionnaire for G1 
where available
3Data taken from pregnancy questionnaires for all
Figure 2. Predicted cases (% of population) of COVID-19 per month according to symptoms reported for those months 
using Menni et al algorithm11.
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‘decreased appetite’ are assumed to capture the same information 
as the symptoms used in the Menni study but may in truth have 
subtly different meaning, leading to either over or under-estimation 
of prevalence in the ALSPAC study. Thirdly, the association 
of these symptoms with COVID-19 (fixed effects in the model) 
is assumed to be the same in the ALSPAC study population as 
the Menni study population. This assumption might be vio-
lated if the pattern of symptom presentation varies in different 
groups of people, leading to over or under-estimation of 
prevalence in the ALSPAC study.
Strengths and limitations of the data
The primary strengths of this data are the timelines within which 
the collection occurred, the retrospectively available and pro-
spectively continuing longitudinal collection forming the context 
for these new data and the potential for cross-cohort com-
parisons with a set of measures aligned to other UK studies. 
We believe the timeframe is important, as the data collected 
here reflects the feelings of the cohort early on in mitigation 
during a period of stringent lockdown measures. In addition 
to this, given that the questionnaire was active for over a month 
it will be important to take date of completion into account 
for certain analyses, as responses may differ between early- 
versus late- completers (e.g. late completers experienced an 
additional month of lockdown measures and have adapted 
more to the new circumstances). Our second COVID-19 data 
collection, funded and planned to start at the end of May will 
provide invaluable comparisons as (at the time of writing) 
some lockdown features are starting to be relaxed (certain 
work sectors being encouraged to return to work etc). Through 
the Wellcome coordinated group developing a core set of 
questions we will be able to make valuable comparisons with 
other  cohort groups of different ages, backgrounds and from 
different countries and cultures. 
We had an excellent response rate; however, it should be noted 
that invitations were only sent to those participants for whom 
we had a valid email address and we have limitations to cover-
age. Our usual questionnaire strategy is to first send emails to 
encourage online completion. We then follow up as part of the 
reminder process and send paper questionnaires through the 
post. This online only strategy will have particularly affected 
G0 mothers who historically have tended to use paper question-
naires more than other sub-groups and for whom we are least 
likely to hold a current email address. However, the pandemic 
has led to a number of participants reaching out and getting in 
touch to provide these details, and indeed to re-engage with 
the study having dropped out previously.
In some cases, the data recorded is potentially identifiable. We 
went through each variable one by one and made decisions about 
whether to combine categories. We have combined categories 
where we feel the data is at high risk of potential disclosure.
A further key limitation of this data is the reduced response 
rate in our male G1 participants (28% of all G1 responders 
were male), even compared to previous data collection exer-
cises in this group where around a third of G1 responders have 
been male. 
Finally, the collection was of course subject to the frequency 
of COVID-19 infection in the population and sample. Very 
few participants reported a positive test to COVID-19 and the 
frequency of algorithmically assigned case status suggests a 
Table 4. Predicted cases of COVID-19 each month using Menni et al. algorithm12 according to  
self-reported infection status (note that valid self-report infection status data available for n=6664 which 
is why the total column is higher than the sum of the other columns).
Tested positive 
(0.01%)
Doctor suspected 
(1.13%)
Participant suspected 
(12.7%)
Not had 
(84.6%)
TOTAL
April 2020 
n=153
0 29 (18.9%) 70 (45.6%) 54 (35.3%) 162 (2.38%)
March 2020 
n=271
0 37 (13.7%) 139 (51.3%) 95 (35.1%) 285 (4.19%)
Feb 2020 
n=137
0 3 (2.2%) 56 (40.9%) 78 (56.9%) 144 (2.11%)
Jan 2020 
n=145
0 0 51 (35.2%) 94 (64.8%) 151 (2.22%)
Dec 2019 
n=136
0 1 (0.7%) 40 (29.4%) 95 (69.9%) 143 (2.10%)
Nov 2019 
n=64
0 1 (1.6%) 15 (23.4%) 48 (75.0%) 70 (1.03%)
Oct 2019 
n=166
0 1 (0.6%) 23 (13.9%) 142 (85.5%) 176 (2.58%)
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frequency of symptomatic presentation which is consistent 
with regional estimates13. This is partly due to UK policy not to 
test widely at the time that data was being collected but also 
the fact that the majority of our participants remain in the 
South-West of England which has had the lowest COVID-19 
death rate in the country (and potentially the lowest infection 
rate14. All symptoms were self-reported but linkage to health 
records and our potential plans to test participants will assist in 
contributing to the evidence around true symptoms of COVID-19.
Data availability
Underlying data
ALSPAC data access is through a system of managed 
open access. The steps below highlight how to apply for 
access to the data included in this data note and all other 
ALSPAC data:
1. Please read the ALSPAC access policy15 which describes 
the process of accessing the data and samples in detail, and 
outlines the costs associated with doing so.
2. You may also find it useful to browse our fully searchable 
research proposals database16, which lists all research projects 
that have been approved since April 2011.
3. Please submit your research proposal17 for consideration by 
the ALSPAC Executive Committee. You will receive a response 
within 10 working days to advise you whether your proposal 
has been approved.
Please note that a standard COVID-19 dataset will be made 
available at no charge (see description below); however, costs 
for required paperwork and any bespoke datasets required 
additional variables will apply.
COVID-19 Questionnaire 1 Data File
Data from the first ALSPAC COVID-19 questionnaire is 
available in two ways.
1.    A freely available standard set of data containing 
all participants together with key sociodemographic 
variables (where available) is available on request 
(see data availability section). Subject to the relevant 
paperwork being completed (costs may apply to cover 
administration) this dataset will be made freely avail-
able to any bona fide researcher requesting it. Variable 
names will follow the format covid1_xxxx where xxxx 
is a four-digit number. A full list of variables released is 
available as extended data10. Frequencies of variable 
and details of any coding/editing decisions and derived 
variables are also available in the data dictionary 
(see extended data10).
2.    Formal release files have been created for G0 
mothers, G0 fathers and G1 participants in the usual 
way and now form part of the ALSPAC resource (Due 
to the small number of G1 partners contributing we will 
not be formally releasing this data, however, it may be 
available on request for specific G2 projects). These 
datasets (or sections therein) can be requested in the 
usual way. Variable names will replicate those in 1) above 
but as each variable in ALSPAC is uniquely defined we 
have added digits to denote the source of the variable. 
For example, in  dataset 1, the age of the participant at 
completion (in years) is denoted by covid1_9650. In the 
mother’s dataset this will be denoted by covid1m_9650, 
for fathers/partner this will be covid1p_9650 and for the 
G1 generation it will be covid1yp_9650. Frequencies for 
all variables for each participant group are available in 
the data dictionary in the usual way18.
Text data and other potentially disclosive information will 
not be released until they have been coded appropriately. 
Table 5 describes the data that is withheld at the time of 
first release. Text from Section C, question 1 and Section D, 
other are being thematically coded by qualitative researchers, 
the remainder will be coded as it is required/requested. Data 
will be incorporated back into both file sets as they become 
available.
Extended data
Open Science Framework: ALSPAC COVID-19 Q1. https://doi.
org/10.17605/OSF.IO/ZU8WY10
This project contains the following extended data:
-    ALSPAC COVID Q1 FINAL.pdf (The final questionnaire; 
REDCap PDF)
-    ALSPAC_COVID1_varlist.pdf (List of variable names and 
labels)
-    ALSPAC_CovidQ1_data dictionary.pdf (Associated data 
dictionary including frequencies of all variables that are 
available)
-    ALSPAC_symptom_algorithm_14052020.do (Stata script 
for obtaining probable COVID-19 cases using the Menni 
algorithm)
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
Consent
Completion of the questionnaire was optional and choosing 
to complete the questionnaire is considered informed consent 
for the questionnaire.
Ethical approval for the study was obtained from the ALSPAC 
Ethics and Law Committee and the Local Research Ethics 
Committees. Informed consent for the use of data collected 
via questionnaires and clinics was obtained from participants 
following the recommendations of the ALSPAC Ethics and 
Law Committee at the time. Study participants have the right to 
withdraw their consent for elements of the study or from the 
study entirely at any time. Full details of the ALSPAC consent 
procedures are available on the study website19.
Page 8 of 10
Wellcome Open Research 2020, 5:127 Last updated: 11 AUG 2020
Acknowledgements
We are extremely grateful to all the families who took part 
in this study, the midwives for their help in recruiting them, 
and the whole ALSPAC team, which includes interview-
ers, computer and laboratory technicians, clerical workers, 
research scientists, volunteers, managers, receptionists and 
nurses.
We are grateful to many people who contributed to the 
design, development, and testing of the questionnaire. Specifically, 
we would like to acknowledge contributions from:
Professor Deborah Lawlor (University of Bristol)
Professor George Davey Smith (University of Bristol)
Professor Peter Vickerman (University of Bristol)
Dr Robert Aldridge (University College London)
Professor David Porteous (University of Edinburgh, Gen Scot)
Honorary Professor Rosie McEachan (University of Bradford, Born 
in Bradford)
Professor Goncalo Abecasis (Regeneron)
Professor Naomi Allen (University of Oxford, UKBB)
Dr Mary de Silva (Wellcome)
Dr Bruna Galobardes (Wellcome)
Dr Claire Steves (Kings College London, TwinsUK)
Professor Stephan Collishaw (University of Cardiff)
Professor Martin Tobin (University of Leicester, EXCEED and 
HDRUK BREATHE)
Table 5. Data from questions that will not be released until coded.
Question 
number
Question text
Section A
1 Please tell us the type of: 
   •   Organ transplant 
   •   Diabetes 
   •   Heart disease or heart problems 
   •   Other lung condition 
   •   Cancer 
   •   Condition affecting the brain and nerves 
   •   Psychiatric disorder 
Please can you tell us why your immune system is weakened?
3 For each medication:  
   •   Name of medication 
   •   Amount 
   •   How often 
   •   Reason for taking
5 Which country do you live in? 
If travelled outside home country:  
   •   Country and region/city/resort 
   •   Date arrived/left 
   •   Purpose of trip
6 What kind of other medical attention did you access? 
What other medication did you take?
9 Date first told had COVID-19
Section B
1 When did you start self-isolating? 
Other reason for self-isolating
2 Other reason for changing normal day to day behaviour
Section C
1 What other reason causing worry
Section D
7 Other type of accommodation lived in
Other Is there anything else you would like to tell us about how the pandemic has affected you?
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